Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine

Int J Antimicrob Agents. 2016 Sep;48(3):347-8. doi: 10.1016/j.ijantimicag.2016.07.002. Epub 2016 Aug 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anticonvulsants / administration & dosage*
  • Antiviral Agents / administration & dosage*
  • Antiviral Agents / adverse effects
  • Antiviral Agents / pharmacokinetics
  • Carbamates
  • Carbamazepine / administration & dosage
  • Carbamazepine / analogs & derivatives*
  • Drug Interactions
  • Drug Therapy, Combination
  • Epilepsy / complications*
  • Epilepsy / drug therapy*
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Imidazoles / administration & dosage*
  • Imidazoles / pharmacokinetics
  • Male
  • Middle Aged
  • Oxcarbazepine
  • Pyrrolidines
  • Sofosbuvir / administration & dosage*
  • Sofosbuvir / pharmacokinetics
  • Treatment Outcome
  • Valine / analogs & derivatives

Substances

  • Anticonvulsants
  • Antiviral Agents
  • Carbamates
  • Imidazoles
  • Pyrrolidines
  • Carbamazepine
  • Valine
  • daclatasvir
  • Oxcarbazepine
  • Sofosbuvir